about
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a di...
Read More
2.79
0.08
(2.95%)
3,439
XNAS Volume
XNAS 07 May, 2026 9:32 AM (EDT)
Board Meeting
The next board meeting for Imunon Inc is on 12 May 2026 for the purpose of Imunon Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Imunon Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..